Concentrations of short-chain fatty acid (SCFA) metabolites were significantly lower in PD patient feces (Unger et al. 2016), significant because SCFAs, produced by specific gut microbes, have been shown to modulate intestinal motility via the enteric nervous system and promote IL-17 expression in γδ T cells. This evidence concerns the gene IL17A and Parkinson disease.